Accolade Inc
General ticker "ACCD" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $287.7M
Accolade Inc does not follow the US Stock Market performance with the rate: -33.6%.
Estimated limits based on current volatility of 2.8%: low 3.27$, high 3.46$
Factors to consider:
- Current price 57.1% below estimated low
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-02-29 to 2026-02-28
- 2024-02-29 to 2025-02-28 estimated range: [8.05$, 15.51$]
- 2025-02-28 to 2026-02-28 estimated range: [7.22$, 14.31$]
Financial Metrics affecting the ACCD estimates:
- Negative: Non-GAAP EPS, $ of -1.33 <= 0.10
- Negative: Operating profit margin, % of -21.65 <= 1.03
- Positive: 1.31 < Industry earnings per price (median), % of 1.42
- Negative: Operating cash flow per share per price, % of -1.73 <= 2.35
- Negative: negative Net income
- Positive: -0.96 < Investing cash flow per share, $ of -0.85
- Positive: 3.85 < Industry operating cash flow per share per price (median), % of 5.19
Short-term ACCD quotes
Long-term ACCD plot with estimates
Financial data
| YTD | 2022-02-28 | 2023-02-28 | 2024-02-29 |
|---|---|---|---|
| Operating Revenue | $310.02MM | $363.14MM | $414.29MM |
| Operating Expenses | $435.75MM | $826.66MM | $528.75MM |
| Operating Income | $-125.72MM | $-463.51MM | $-114.45MM |
| Non-Operating Income | $-3.04MM | $0.24MM | $15.88MM |
| Interest Expense | $2.90MM | $0.26MM | $0.00MM |
| R&D Expense | $83.66MM | $101.35MM | $99.16MM |
| Income(Loss) | $-128.76MM | $-463.27MM | $-98.57MM |
| Taxes | $-5.64MM | $-3.62MM | $1.24MM |
| Profit(Loss) | $-123.12MM | $-459.65MM | $-99.81MM |
| Stockholders Equity | $855.79MM | $473.79MM | $445.46MM |
| Inventory | $3.02MM | $4.02MM | $15.81MM |
| Assets | $1,285.53MM | $903.07MM | $788.15MM |
| Operating Cash Flow | $-62.35MM | $-40.70MM | $-16.17MM |
| Capital expenditure | $3.62MM | $7.23MM | $12.48MM |
| Investing Cash Flow | $-263.61MM | $-7.23MM | $-63.63MM |
| Financing Cash Flow | $257.93MM | $3.16MM | $-55.57MM |
| Earnings Per Share* | $-1.93 | $-6.45 | $-1.33 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.